Physician
Radiation Oncology
Doctor Neil N. Senzer, MD practices Radiation Oncology. He graduated from University at Buffalo, School of Medicine and Biomedical Sciences. He received awards:"Top MD". Neil Senzer is a published physician as well. He has 21 publications published. The latest was: Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors.
Publications
- Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid Tumors.
- Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic Cancer via a novel bifunctional RNAi platform.
- Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine.
- Phase 1 study of N (1),N (11)-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
- A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours.
- Phase I Study of a Systemically DeLivered p53 Nanoparticle in Advanced Solid Tumors.
- Immune response and survival of refractory Cancer patients who received TGF-?2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.
- RNA interference and personalized Cancer therapy.
- Tivantinib (ARQ 197), a selective inhibitor of mesenchymal-epithelial transition factor, in patients with microphthalmia transcription factor-associated Tumors: Result...
- Bifunctional short hairpin RNA (bi-shRNA): design and pathway to clinical application.
- Reversible masking using low-molecular-weight neutral lipids to achieve optimal-targeted deLivery.
- Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal Cancer.
- Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.
- A Phase I Dose Esclation Study of Tivantinib (ARQ 197) in Adult Pts w Metastatic Solid Tumors.
- Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid Tumors with neuroendocrine features.
- Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung Cancer.
- Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adju...
- Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastati...
- Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities.
- Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell can...
Schools
State University of New York At Buffalo
Johns Hopkins Hospital
St Barnabas Med Center
St Jude Chldns Rsch Hospital
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
Accepted Insurances
Awards
Education
-
St Barnabas Medical Center
-
Johns Hopkins University
-
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
Baylor University Medical Center
-
Medical City Dallas Hospital
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.